A Review of Published Cases Regarding the Amphotericin B Deoxycholate Overdose in the Pediatric Population and a Case Report
- 1 June 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 20 (4) , 415-422
Abstract
Considering the fact that two available and commonly used formulations of amphotericin B could be used instead of each other by mistake. Also, an updated and comprehensive data regarding management of this medication error was not available; the current review was conducted to gather available data among the pediatric population and discuss management and outcome of patients in case such an error occurs. We review all the cases of amphotericin B overdose which reported in PubMed and google scholar so far then discuss an 8-years-old girl diagnosed with Ewing sarcoma who inadvertently received five times more than therapeutic dose of amphotericin B deoxycholate (5mg/kg/day).In total, ten of the cases were exactly matched to our purpose of the study. In our case, fluid and electrolyte management was aggressively undertaken and she was put under cardiac monitoring for 7 days following detection of the medication error. Finally, she was discharged from hospital with stable condition. Reviewed data in this manuscript showed that amphotericin B deoxycholate overdose could cause severe complications and lead to cardio toxicity, electrolyte imbalance and death. Aggressive cardiac, fluid and electrolyte monitoring and management of any problem as soon as they were detected was the pathway followed by the authors of this review and others who faced this medication error. The role of NAC and hydrocortisone in the managing amphotericin B deoxycholate overdose requires further investigation.Keywords
This publication has 15 references indexed in Scilit:
- Is it possible to attenuate amphotericin B-induced electrolyte imbalances in children with N-acetylcysteine?Trace Elements and Electrolytes, 2021
- Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin BClinical Infectious Diseases, 2019
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- Amphotericin-B overdoseReactions Weekly, 2016
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2015
- A double-blinded, placebo-controlled, multicenter clinical trial ofN-acetylcysteine for preventing amphotericin B-induced nephrotoxicityExpert Opinion on Drug Metabolism & Toxicology, 2015
- Reduction of Amphotericin B-Induced Renal Tubular Apoptosis by N -AcetylcysteineAntimicrobial Agents and Chemotherapy, 2009
- Amphotericin B-deoxycholate overdose due to administration error in pediatric patientsMedical Mycology, 2008
- Clinical Course and Pharmacokinetics Following a Massive Overdose of Amphotericin B in a NeonateJournal of Toxicology: Clinical Toxicology, 1990
- Pharmacokinetics of amphotericin B in childrenAntimicrobial Agents and Chemotherapy, 1989